Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,700 | 64,700 | 71,000 | 47,000 | 20,900 |
| Receivables | 860,600 | 946,200 | 966,800 | 906,100 | 952,100 |
| Inventories | 856,600 | 1,014,300 | 1,038,300 | 1,086,300 | 1,079,200 |
| Other current assets | 203,700 | 226,700 | 217,400 | 203,000 | 212,300 |
| TOTAL | $1,969,600 | $2,251,900 | $2,293,500 | $2,242,400 | $2,264,500 |
| Non-Current Assets | |||||
| PPE Net | 1,158,400 | 1,208,500 | 1,199,500 | 1,196,800 | 1,205,100 |
| Investments And Advances | 72,400 | 0 | 0 | 0 | 0 |
| Intangibles | 1,789,600 | 1,946,900 | 1,960,200 | 1,976,200 | 1,989,400 |
| Other Non-Current Assets | 280,500 | 344,100 | 362,600 | 317,300 | 305,100 |
| TOTAL | $3,300,900 | $3,499,500 | $3,522,300 | $3,490,300 | $3,499,600 |
| Total Assets | $5,270,500 | $5,751,400 | $5,815,800 | $5,732,700 | $5,764,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,400 | 1,300 | 6,400 | 12,400 | 12,400 |
| Accounts payable and accrued liabilities | 313,400 | 346,800 | 285,200 | 258,800 | 291,800 |
| Accrued Expenses | 552,500 | 555,100 | 483,700 | 434,400 | 554,800 |
| TOTAL | $1,228,000 | $1,721,500 | $1,707,100 | $2,012,600 | $2,039,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 950,300 | 951,200 | 951,300 | 1,151,600 | 1,151,800 |
| Other Non-Current Liabilities | 762,300 | 758,600 | 768,700 | 379,900 | 381,600 |
| TOTAL | $1,939,800 | $1,943,800 | $1,960,800 | $1,589,500 | $1,588,300 |
| Total Liabilities | $3,167,800 | $3,665,300 | $3,667,900 | $3,602,100 | $3,628,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 149,602 | 148,589 | 152,012 | 152,846 | 153,760 |
| Common Shares | 717,400 | 717,400 | 717,400 | 717,400 | 717,400 |
| Retained earnings | 4,157,700 | 4,028,600 | 4,010,100 | 3,944,100 | 3,919,700 |
| Other shareholders' equity | -122,600 | -89,200 | -106,600 | -103,000 | -70,100 |
| TOTAL | $2,102,700 | $2,086,100 | $2,147,900 | $2,130,600 | $2,135,900 |
| Total Liabilities And Equity | $5,270,500 | $5,751,400 | $5,815,800 | $5,732,700 | $5,764,100 |